Anti-inflammatory Effects
By Cosmetic Peat Editorial Team Updated June 2026
Inflammation is the body’s alarm system — when tissue is damaged or irritated, immune cells release chemical signals that bring blood flow, swelling, and pain to the area. In conditions like psoriasis, eczema, and joint inflammation, this alarm gets stuck in the “on” position, causing chronic damage instead of repair.
Peat’s anti-inflammatory effect is its most clinically significant mechanism — and it works through the same pathways that pharmaceutical anti-inflammatory drugs target.
How it works
When you take ibuprofen, it blocks cyclooxygenase (COX) enzymes to reduce inflammatory signalling. Humic acids and fulvic acids in peat target the same general problem — but through a broader set of pathways, delivered through the skin rather than the bloodstream.
The targets. Peat compounds suppress three key inflammatory signals: TNF-α, IL-1β, and IL-6. These are the cytokines that drive redness, swelling, and pain in everything from arthritic joints to psoriatic plaques. Humic acids also inhibit the NF-κB pathway — the master switch that controls whether inflammatory genes get turned on at all (Klöcking 2005, van Rensburg 2015).
Two compounds, two channels. Humic acids provide broad cytokine suppression — reducing TNF-α, IL-6, and IL-1β while preserving the protective anti-inflammatory signal IL-10 (Verrillo 2022). Fulvic acids add a more targeted channel: they block the chemokines CCL17 and CCL22 by deactivating the p38 MAPK and JNK pathways in skin cells (Wu 2023). This dual action is why peat’s anti-inflammatory effect is broader than any single pharmaceutical compound.
An interesting twist. Humic acids show a dose-dependent bimodal effect: at low concentrations (10–80 μg/mL) they actually increase TNF-α threefold, while at higher concentrations (>100 μg/mL) they decrease it tenfold. This isn’t a flaw — it may reflect a genuine immunomodulatory function where low doses stimulate a healthy immune response while high doses suppress an overactive one.
Why it matters
Anti-inflammatory effects are the mechanism behind peat’s benefits for the widest range of conditions:
- Psoriasis — suppresses the inflammatory cascade driving plaque formation. Systematic reviews confirm balneotherapy efficacy (Jazani 2022).
- Eczema — reduces skin inflammation via CCL17/CCL22 downregulation. Demonstrated in atopic dermatitis mouse models (Wu 2023, Zhernov 2020).
- Joint inflammation — combined with thermal retention, reduces joint swelling and pain. Supported by multiple RCTs and a meta-analysis (Bender 2013).
- Seborrheic dermatitis — calms scalp inflammation alongside antimicrobial effects.
In peat baths, the anti-inflammatory mechanism works in synergy with sustained heat — the warmth increases blood flow and skin permeability, helping the bioactive compounds reach their targets more effectively. This thermal-chemical synergy is what distinguishes peat therapy from both pharmaceutical anti-inflammatories (chemistry without heat) and hot water baths (heat without chemistry).
The evidence
In-vitro evidence for cytokine inhibition is strong — multiple studies confirm the effect across different humic substance preparations. Clinical evidence varies by condition: strongest for joint inflammation (multiple RCTs, meta-analysis, Grade A evidence), moderate for dermatological conditions like psoriasis and eczema (cohort studies, systematic reviews), and preliminary for scalp conditions.
How It Works
| Targets | TNF-α, IL-1β, IL-6, NF-κB |
| Pathway | NF-κB inhibition, cyclooxygenase modulation |